Legal Representation
Attorney
POLLIE GAUTSCH
USPTO Deadlines 2 active
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | Oct 01, 2025 | 86 days | Critical | Until Jan 01, 2026 |
|
OFFICE ACTION
Non-Final Action Mailed |
CNRT | Oct 01, 2025 | 86 days | Critical | Until Jan 01, 2026 |
Next deadline: Non-Final Action Mailed
on October 01, 2025
(86 days)
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 2, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 1, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 1, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 1, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 1, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 1, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| May 5, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| May 5, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 5, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Dietary and nutritional supplements; Dietary and nutritional supplements containing pyrroloquinoline quinone (PQQ); Nutraceuticals for use as a dietary supplement; Dietary and nutritional supplements for humans and animals; Vitamin and mineral supplements; Dietary supplements in the form of powders, gummies, liquids, tablets and capsules containing pyrroloquinoline quinone (PQQ); Dietary and nutritional supplements for support of energy levels, immune function, and mitochondria function; Nutraceuticals for use as a dietary supplement for containing pyrroloquinoline quinone (PQQ); all the foregoing containing pyrroloquinoline quinone (PQQ)
First Use Anywhere:
Apr 29, 2025
First Use in Commerce:
Apr 29, 2025
Classification
International Classes
005